Abstract Details

Title Identifying Patients with Relapsing-Remitting Multiple Sclerosis Who Have Aggressive Disease Characterized by Rapid Disability Progression

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 093

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Thomas F. Scott, MD (AHN Neurology)	Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Scott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serono. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme.
Genevieve A. Laforet, MD, PhD (Genzyme, a Sanofi Company)	No disclosure on file
Xiaojun You, PhD (Biogen Idec Inc.)	No disclosure on file
John M. Bertoni, MD, PhD, F�鶹��ýӳ�� (University of Nebraska Medical Center)	Dr. Bertoni has nothing to disclose.

�鶹��ýӳ��